nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—systemic lupus erythematosus	0.206	1	CbGaD
Bumetanide—SLC10A1—Cyclosporine—systemic lupus erythematosus	0.122	0.213	CbGbCtD
Bumetanide—PTGS2—Dapsone—systemic lupus erythematosus	0.0463	0.0808	CbGbCtD
Bumetanide—SLCO1A2—Prednisolone—systemic lupus erythematosus	0.0414	0.0724	CbGbCtD
Bumetanide—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0401	0.07	CbGbCtD
Bumetanide—SLCO1A2—Hydrocortisone—systemic lupus erythematosus	0.0393	0.0686	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—systemic lupus erythematosus	0.0391	0.0683	CbGbCtD
Bumetanide—SLCO1A2—Cyclosporine—systemic lupus erythematosus	0.0371	0.0648	CbGbCtD
Bumetanide—PTGS2—Betamethasone—systemic lupus erythematosus	0.0344	0.0601	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—systemic lupus erythematosus	0.0294	0.0513	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—systemic lupus erythematosus	0.028	0.0489	CbGbCtD
Bumetanide—SLCO1A2—Dexamethasone—systemic lupus erythematosus	0.0244	0.0427	CbGbCtD
Bumetanide—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0225	0.0393	CbGbCtD
Bumetanide—PTGS2—Dexamethasone—systemic lupus erythematosus	0.02	0.035	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—systemic lupus erythematosus	0.0196	0.0343	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—systemic lupus erythematosus	0.0171	0.0299	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—systemic lupus erythematosus	0.0119	0.0208	CbGbCtD
Bumetanide—SLC22A8—choroid plexus—systemic lupus erythematosus	0.0105	0.131	CbGeAlD
Bumetanide—SLC12A1—urine—systemic lupus erythematosus	0.00484	0.0606	CbGeAlD
Bumetanide—SLC22A8—urine—systemic lupus erythematosus	0.00281	0.0352	CbGeAlD
Bumetanide—SLC12A1—blood plasma—systemic lupus erythematosus	0.00252	0.0316	CbGeAlD
Bumetanide—SLC12A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00188	0.0678	CbGpPWpGaD
Bumetanide—SLC12A4—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00188	0.0678	CbGpPWpGaD
Bumetanide—SLC12A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.0016	0.0576	CbGpPWpGaD
Bumetanide—SLC12A5—nervous system—systemic lupus erythematosus	0.00156	0.0196	CbGeAlD
Bumetanide—CFTR—kidney—systemic lupus erythematosus	0.00155	0.0195	CbGeAlD
Bumetanide—SLC12A2—nephron tubule—systemic lupus erythematosus	0.00155	0.0195	CbGeAlD
Bumetanide—CA7—kidney—systemic lupus erythematosus	0.00153	0.0192	CbGeAlD
Bumetanide—SLC12A5—central nervous system—systemic lupus erythematosus	0.0015	0.0188	CbGeAlD
Bumetanide—SLC12A4—lung—systemic lupus erythematosus	0.0014	0.0176	CbGeAlD
Bumetanide—SLC12A2—kidney—systemic lupus erythematosus	0.00136	0.0171	CbGeAlD
Bumetanide—SLC22A11—nephron tubule—systemic lupus erythematosus	0.00134	0.0168	CbGeAlD
Bumetanide—SLC12A2—cortex of kidney—systemic lupus erythematosus	0.00133	0.0167	CbGeAlD
Bumetanide—SLC12A1—nephron tubule—systemic lupus erythematosus	0.0013	0.0163	CbGeAlD
Bumetanide—SLC12A4—nervous system—systemic lupus erythematosus	0.0013	0.0163	CbGeAlD
Bumetanide—SLC10A1—kidney—systemic lupus erythematosus	0.00129	0.0162	CbGeAlD
Bumetanide—SLC22A6—nephron tubule—systemic lupus erythematosus	0.00126	0.0158	CbGeAlD
Bumetanide—SLC12A4—central nervous system—systemic lupus erythematosus	0.00125	0.0157	CbGeAlD
Bumetanide—SLC22A11—kidney—systemic lupus erythematosus	0.00118	0.0148	CbGeAlD
Bumetanide—CA12—connective tissue—systemic lupus erythematosus	0.00117	0.0146	CbGeAlD
Bumetanide—SLC22A7—kidney—systemic lupus erythematosus	0.00115	0.0144	CbGeAlD
Bumetanide—SLC22A11—cortex of kidney—systemic lupus erythematosus	0.00115	0.0144	CbGeAlD
Bumetanide—SLC12A1—kidney—systemic lupus erythematosus	0.00114	0.0143	CbGeAlD
Bumetanide—SLC22A7—cortex of kidney—systemic lupus erythematosus	0.00112	0.014	CbGeAlD
Bumetanide—SLC12A1—cortex of kidney—systemic lupus erythematosus	0.00111	0.014	CbGeAlD
Bumetanide—SLC12A2—tendon—systemic lupus erythematosus	0.0011	0.0138	CbGeAlD
Bumetanide—CFTR—lung—systemic lupus erythematosus	0.0011	0.0138	CbGeAlD
Bumetanide—CA9—tendon—systemic lupus erythematosus	0.00108	0.0136	CbGeAlD
Bumetanide—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.00108	0.0135	CbGeAlD
Bumetanide—SLC12A2—bone marrow—systemic lupus erythematosus	0.00107	0.0134	CbGeAlD
Bumetanide—CA14—tendon—systemic lupus erythematosus	0.00103	0.0129	CbGeAlD
Bumetanide—CA12—kidney—systemic lupus erythematosus	0.000994	0.0125	CbGeAlD
Bumetanide—SLC12A2—lung—systemic lupus erythematosus	0.000967	0.0121	CbGeAlD
Bumetanide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.000953	0.0343	CbGpPWpGaD
Bumetanide—PTGS2—endothelium—systemic lupus erythematosus	0.000936	0.0117	CbGeAlD
Bumetanide—SLC12A2—nervous system—systemic lupus erythematosus	0.000895	0.0112	CbGeAlD
Bumetanide—SLC12A2—central nervous system—systemic lupus erythematosus	0.000862	0.0108	CbGeAlD
Bumetanide—SLC10A1—nervous system—systemic lupus erythematosus	0.000846	0.0106	CbGeAlD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000842	0.0303	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000842	0.0303	CbGpPWpGaD
Bumetanide—PTGS2—blood plasma—systemic lupus erythematosus	0.000831	0.0104	CbGeAlD
Bumetanide—SLC10A1—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000828	0.0298	CbGpPWpGaD
Bumetanide—SLC10A1—central nervous system—systemic lupus erythematosus	0.000814	0.0102	CbGeAlD
Bumetanide—SLC22A8—nephron tubule—systemic lupus erythematosus	0.000756	0.00947	CbGeAlD
Bumetanide—SLC12A1—nervous system—systemic lupus erythematosus	0.000751	0.00941	CbGeAlD
Bumetanide—SLC12A1—central nervous system—systemic lupus erythematosus	0.000723	0.00906	CbGeAlD
Bumetanide—SLC10A1—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000722	0.026	CbGpPWpGaD
Bumetanide—CA5B—tendon—systemic lupus erythematosus	0.00072	0.00902	CbGeAlD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000716	0.0258	CbGpPWpGaD
Bumetanide—SLC10A1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000714	0.0257	CbGpPWpGaD
Bumetanide—CA12—lung—systemic lupus erythematosus	0.000704	0.00882	CbGeAlD
Bumetanide—CA4—nephron tubule—systemic lupus erythematosus	0.0007	0.00877	CbGeAlD
Bumetanide—SLCO1A2—kidney—systemic lupus erythematosus	0.000696	0.00872	CbGeAlD
Bumetanide—SLC22A8—kidney—systemic lupus erythematosus	0.000664	0.00832	CbGeAlD
Bumetanide—CA12—nervous system—systemic lupus erythematosus	0.000652	0.00817	CbGeAlD
Bumetanide—SLC22A8—cortex of kidney—systemic lupus erythematosus	0.000647	0.00811	CbGeAlD
Bumetanide—CA5B—lung—systemic lupus erythematosus	0.000632	0.00792	CbGeAlD
Bumetanide—CA12—central nervous system—systemic lupus erythematosus	0.000628	0.00787	CbGeAlD
Bumetanide—CA4—kidney—systemic lupus erythematosus	0.000615	0.00771	CbGeAlD
Bumetanide—CA4—cortex of kidney—systemic lupus erythematosus	0.000599	0.00751	CbGeAlD
Bumetanide—CA5B—nervous system—systemic lupus erythematosus	0.000585	0.00733	CbGeAlD
Bumetanide—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.000585	0.021	CbGpPWpGaD
Bumetanide—CA5B—central nervous system—systemic lupus erythematosus	0.000563	0.00706	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.00052	0.159	CbGdCrCtD
Bumetanide—Stevens-Johnson syndrome—Azathioprine—systemic lupus erythematosus	0.000516	0.00474	CcSEcCtD
Bumetanide—Furosemide—ALB—systemic lupus erythematosus	0.000516	0.396	CrCbGaD
Bumetanide—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000512	0.156	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000512	0.156	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.0005	0.153	CbGdCrCtD
Bumetanide—Hyperglycaemia—Leflunomide—systemic lupus erythematosus	0.000497	0.00457	CcSEcCtD
Bumetanide—CA4—tendon—systemic lupus erythematosus	0.000497	0.00623	CbGeAlD
Bumetanide—SLCO1A2—lung—systemic lupus erythematosus	0.000493	0.00618	CbGeAlD
Bumetanide—Stevens-Johnson syndrome—Leflunomide—systemic lupus erythematosus	0.000487	0.00448	CcSEcCtD
Bumetanide—Renal failure—Leflunomide—systemic lupus erythematosus	0.000483	0.00444	CcSEcCtD
Bumetanide—Hyponatraemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000482	0.00443	CcSEcCtD
Bumetanide—CA4—bone marrow—systemic lupus erythematosus	0.000481	0.00603	CbGeAlD
Bumetanide—Gastrointestinal pain—Dapsone—systemic lupus erythematosus	0.00048	0.00441	CcSEcCtD
Bumetanide—SLC10A1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.00047	0.0169	CbGpPWpGaD
Bumetanide—Abdominal pain—Dapsone—systemic lupus erythematosus	0.000464	0.00427	CcSEcCtD
Bumetanide—Blood creatinine increased—Cyclosporine—systemic lupus erythematosus	0.000461	0.00424	CcSEcCtD
Bumetanide—SLCO1A2—nervous system—systemic lupus erythematosus	0.000456	0.00572	CbGeAlD
Bumetanide—Blood creatinine increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00045	0.00413	CcSEcCtD
Bumetanide—Dehydration—Mycophenolate mofetil—systemic lupus erythematosus	0.000447	0.0041	CcSEcCtD
Bumetanide—Cramp muscle—Cyclosporine—systemic lupus erythematosus	0.000443	0.00407	CcSEcCtD
Bumetanide—PTGS2—connective tissue—systemic lupus erythematosus	0.000442	0.00554	CbGeAlD
Bumetanide—Erythema multiforme—Azathioprine—systemic lupus erythematosus	0.000442	0.00406	CcSEcCtD
Bumetanide—SLCO1A2—central nervous system—systemic lupus erythematosus	0.000439	0.00551	CbGeAlD
Bumetanide—Hypokalaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000437	0.00402	CcSEcCtD
Bumetanide—CA4—lung—systemic lupus erythematosus	0.000436	0.00546	CbGeAlD
Bumetanide—SLC22A8—nervous system—systemic lupus erythematosus	0.000436	0.00546	CbGeAlD
Bumetanide—SLC10A1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000433	0.0156	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000428	0.0154	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000428	0.0154	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000428	0.0154	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000426	0.0153	CbGpPWpGaD
Bumetanide—SLC22A8—central nervous system—systemic lupus erythematosus	0.00042	0.00526	CbGeAlD
Bumetanide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—systemic lupus erythematosus	0.000418	0.015	CbGpPWpGaD
Bumetanide—Erythema multiforme—Leflunomide—systemic lupus erythematosus	0.000417	0.00383	CcSEcCtD
Bumetanide—Pancreatitis—Cyclosporine—systemic lupus erythematosus	0.000417	0.00383	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—systemic lupus erythematosus	0.000415	0.319	CrCbGaD
Bumetanide—Abdominal discomfort—Cyclosporine—systemic lupus erythematosus	0.000408	0.00375	CcSEcCtD
Bumetanide—SLCO1A2—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000407	0.0147	CbGpPWpGaD
Bumetanide—Pancreatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000407	0.00374	CcSEcCtD
Bumetanide—Hyperuricaemia—Methotrexate—systemic lupus erythematosus	0.000404	0.00371	CcSEcCtD
Bumetanide—CA4—nervous system—systemic lupus erythematosus	0.000404	0.00506	CbGeAlD
Bumetanide—PTGS2—skin of body—systemic lupus erythematosus	0.0004	0.00501	CbGeAlD
Bumetanide—Hypokalaemia—Hydrocortisone—systemic lupus erythematosus	0.000398	0.00366	CcSEcCtD
Bumetanide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—systemic lupus erythematosus	0.000396	0.0142	CbGpPWpGaD
Bumetanide—CA4—central nervous system—systemic lupus erythematosus	0.000389	0.00487	CbGeAlD
Bumetanide—Hyperglycaemia—Cyclosporine—systemic lupus erythematosus	0.000384	0.00353	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—systemic lupus erythematosus	0.000382	0.00351	CcSEcCtD
Bumetanide—Pancreatitis—Prednisolone—systemic lupus erythematosus	0.00038	0.00349	CcSEcCtD
Bumetanide—PTGS2—kidney—systemic lupus erythematosus	0.000377	0.00472	CbGeAlD
Bumetanide—Hyperglycaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000374	0.00344	CcSEcCtD
Bumetanide—Vomiting—Dapsone—systemic lupus erythematosus	0.000373	0.00343	CcSEcCtD
Bumetanide—Renal failure—Cyclosporine—systemic lupus erythematosus	0.000373	0.00343	CcSEcCtD
Bumetanide—Pancreatitis—Hydrocortisone—systemic lupus erythematosus	0.000371	0.00341	CcSEcCtD
Bumetanide—Fenoprofen—ALB—systemic lupus erythematosus	0.00037	0.285	CrCbGaD
Bumetanide—Muscle spasms—Leflunomide—systemic lupus erythematosus	0.000369	0.00339	CcSEcCtD
Bumetanide—Headache—Dapsone—systemic lupus erythematosus	0.000368	0.00338	CcSEcCtD
Bumetanide—Leukopenia—Azathioprine—systemic lupus erythematosus	0.000364	0.00335	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000364	0.0131	CbGpPWpGaD
Bumetanide—Renal failure—Mycophenolate mofetil—systemic lupus erythematosus	0.000364	0.00334	CcSEcCtD
Bumetanide—Sweating—Mycophenolate mofetil—systemic lupus erythematosus	0.000355	0.00326	CcSEcCtD
Bumetanide—Pancreatitis—Triamcinolone—systemic lupus erythematosus	0.000349	0.00321	CcSEcCtD
Bumetanide—Nausea—Dapsone—systemic lupus erythematosus	0.000349	0.0032	CcSEcCtD
Bumetanide—Pancreatitis—Methylprednisolone—systemic lupus erythematosus	0.000348	0.0032	CcSEcCtD
Bumetanide—Arthralgia—Azathioprine—systemic lupus erythematosus	0.000346	0.00318	CcSEcCtD
Bumetanide—Vertigo—Leflunomide—systemic lupus erythematosus	0.000345	0.00317	CcSEcCtD
Bumetanide—Leukopenia—Leflunomide—systemic lupus erythematosus	0.000344	0.00316	CcSEcCtD
Bumetanide—Hypokalaemia—Betamethasone—systemic lupus erythematosus	0.00034	0.00313	CcSEcCtD
Bumetanide—Hypokalaemia—Dexamethasone—systemic lupus erythematosus	0.00034	0.00313	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—systemic lupus erythematosus	0.000335	0.00308	CcSEcCtD
Bumetanide—Chest pain—Leflunomide—systemic lupus erythematosus	0.000327	0.00301	CcSEcCtD
Bumetanide—Arthralgia—Leflunomide—systemic lupus erythematosus	0.000327	0.00301	CcSEcCtD
Bumetanide—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000325	0.00299	CcSEcCtD
Bumetanide—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000324	0.00405	CbGeAlD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—systemic lupus erythematosus	0.000322	0.0116	CbGpPWpGaD
Bumetanide—Dry mouth—Leflunomide—systemic lupus erythematosus	0.00032	0.00294	CcSEcCtD
Bumetanide—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000314	0.0958	CbGdCrCtD
Bumetanide—SLCO1A2—Transport of organic anions—ALB—systemic lupus erythematosus	0.000312	0.0112	CbGpPWpGaD
Bumetanide—Hypotension—Azathioprine—systemic lupus erythematosus	0.00031	0.00285	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—systemic lupus erythematosus	0.00031	0.00285	CcSEcCtD
Bumetanide—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000309	0.0942	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000309	0.0942	CbGdCrCtD
Bumetanide—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000307	0.00282	CcSEcCtD
Bumetanide—PTGS2—tendon—systemic lupus erythematosus	0.000304	0.00381	CbGeAlD
Bumetanide—Sweating—Methylprednisolone—systemic lupus erythematosus	0.000304	0.00279	CcSEcCtD
Bumetanide—Hyperhidrosis—Leflunomide—systemic lupus erythematosus	0.000303	0.00279	CcSEcCtD
Bumetanide—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000302	0.0921	CbGdCrCtD
Bumetanide—Hypokalaemia—Prednisone—systemic lupus erythematosus	0.000296	0.00272	CcSEcCtD
Bumetanide—PTGS2—bone marrow—systemic lupus erythematosus	0.000295	0.00369	CbGeAlD
Bumetanide—Hypotension—Leflunomide—systemic lupus erythematosus	0.000293	0.00269	CcSEcCtD
Bumetanide—Hyperglycaemia—Dexamethasone—systemic lupus erythematosus	0.000291	0.00268	CcSEcCtD
Bumetanide—Hyperglycaemia—Betamethasone—systemic lupus erythematosus	0.000291	0.00268	CcSEcCtD
Bumetanide—CA9—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000291	0.0105	CbGpPWpGaD
Bumetanide—Muscle spasms—Cyclosporine—systemic lupus erythematosus	0.000285	0.00262	CcSEcCtD
Bumetanide—PTGS2—C-MYB transcription factor network—PRTN3—systemic lupus erythematosus	0.00028	0.0101	CbGpPWpGaD
Bumetanide—Muscle spasms—Mycophenolate mofetil—systemic lupus erythematosus	0.000278	0.00256	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—systemic lupus erythematosus	0.000276	0.00253	CcSEcCtD
Bumetanide—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000271	0.00249	CcSEcCtD
Bumetanide—Fatigue—Leflunomide—systemic lupus erythematosus	0.00027	0.00248	CcSEcCtD
Bumetanide—PTGS2—lung—systemic lupus erythematosus	0.000267	0.00334	CbGeAlD
Bumetanide—Vertigo—Cyclosporine—systemic lupus erythematosus	0.000266	0.00245	CcSEcCtD
Bumetanide—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000265	0.00244	CcSEcCtD
Bumetanide—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000262	0.00241	CcSEcCtD
Bumetanide—Vertigo—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.00239	CcSEcCtD
Bumetanide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000259	0.00238	CcSEcCtD
Bumetanide—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000256	0.00236	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000254	0.00914	CbGpPWpGaD
Bumetanide—Hyperglycaemia—Prednisone—systemic lupus erythematosus	0.000254	0.00233	CcSEcCtD
Bumetanide—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000252	0.00232	CcSEcCtD
Bumetanide—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000252	0.00232	CcSEcCtD
Bumetanide—Urticaria—Leflunomide—systemic lupus erythematosus	0.000249	0.00229	CcSEcCtD
Bumetanide—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000248	0.00228	CcSEcCtD
Bumetanide—PTGS2—nervous system—systemic lupus erythematosus	0.000247	0.0031	CbGeAlD
Bumetanide—Dry mouth—Cyclosporine—systemic lupus erythematosus	0.000247	0.00227	CcSEcCtD
Bumetanide—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00226	CcSEcCtD
Bumetanide—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00226	CcSEcCtD
Bumetanide—SLC10A1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000246	0.00884	CbGpPWpGaD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	0.000245	0.00225	CcSEcCtD
Bumetanide—Vertigo—Prednisolone—systemic lupus erythematosus	0.000242	0.00223	CcSEcCtD
Bumetanide—Dry mouth—Mycophenolate mofetil—systemic lupus erythematosus	0.000241	0.00221	CcSEcCtD
Bumetanide—PTGS2—Spinal Cord Injury—TNFSF13B—systemic lupus erythematosus	0.00024	0.00863	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000239	0.00859	CbGpPWpGaD
Bumetanide—PTGS2—central nervous system—systemic lupus erythematosus	0.000238	0.00298	CbGeAlD
Bumetanide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000237	0.00218	CcSEcCtD
Bumetanide—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000237	0.00218	CcSEcCtD
Bumetanide—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000234	0.00215	CcSEcCtD
Bumetanide—SLCO1A2—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000231	0.00832	CbGpPWpGaD
Bumetanide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000231	0.00212	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—systemic lupus erythematosus	0.000231	0.00212	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000231	0.00829	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000228	0.0021	CcSEcCtD
Bumetanide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000227	0.00209	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000225	0.00207	CcSEcCtD
Bumetanide—Asthenia—Leflunomide—systemic lupus erythematosus	0.000225	0.00207	CcSEcCtD
Bumetanide—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000223	0.00205	CcSEcCtD
Bumetanide—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000222	0.00204	CcSEcCtD
Bumetanide—Pruritus—Leflunomide—systemic lupus erythematosus	0.000222	0.00204	CcSEcCtD
Bumetanide—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00203	CcSEcCtD
Bumetanide—Dizziness—Azathioprine—systemic lupus erythematosus	0.00022	0.00202	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000216	0.00778	CbGpPWpGaD
Bumetanide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000215	0.00197	CcSEcCtD
Bumetanide—SLCO1A2—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000213	0.00766	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000213	0.00196	CcSEcCtD
Bumetanide—Vomiting—Azathioprine—systemic lupus erythematosus	0.000211	0.00194	CcSEcCtD
Bumetanide—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000211	0.00194	CcSEcCtD
Bumetanide—Rash—Azathioprine—systemic lupus erythematosus	0.000209	0.00192	CcSEcCtD
Bumetanide—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000209	0.00192	CcSEcCtD
Bumetanide—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000209	0.00192	CcSEcCtD
Bumetanide—Headache—Azathioprine—systemic lupus erythematosus	0.000208	0.00191	CcSEcCtD
Bumetanide—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000208	0.00191	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	0.000208	0.00191	CcSEcCtD
Bumetanide—Dizziness—Leflunomide—systemic lupus erythematosus	0.000207	0.00191	CcSEcCtD
Bumetanide—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000207	0.0019	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—systemic lupus erythematosus	0.000206	0.00189	CcSEcCtD
Bumetanide—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000202	0.00186	CcSEcCtD
Bumetanide—Vertigo—Betamethasone—systemic lupus erythematosus	0.000202	0.00186	CcSEcCtD
Bumetanide—Sweating—Methotrexate—systemic lupus erythematosus	0.000201	0.00185	CcSEcCtD
Bumetanide—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000201	0.00185	CcSEcCtD
Bumetanide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000199	0.00183	CcSEcCtD
Bumetanide—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000198	0.00182	CcSEcCtD
Bumetanide—Rash—Leflunomide—systemic lupus erythematosus	0.000198	0.00182	CcSEcCtD
Bumetanide—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000197	0.00181	CcSEcCtD
Bumetanide—Nausea—Azathioprine—systemic lupus erythematosus	0.000197	0.00181	CcSEcCtD
Bumetanide—Headache—Leflunomide—systemic lupus erythematosus	0.000196	0.0018	CcSEcCtD
Bumetanide—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000196	0.0018	CcSEcCtD
Bumetanide—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000195	0.00179	CcSEcCtD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000194	0.00697	CbGpPWpGaD
Bumetanide—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000193	0.00177	CcSEcCtD
Bumetanide—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000192	0.00177	CcSEcCtD
Bumetanide—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000191	0.00176	CcSEcCtD
Bumetanide—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000189	0.00173	CcSEcCtD
Bumetanide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.00172	CcSEcCtD
Bumetanide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000187	0.00171	CcSEcCtD
Bumetanide—Nausea—Leflunomide—systemic lupus erythematosus	0.000186	0.00171	CcSEcCtD
Bumetanide—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000185	0.0017	CcSEcCtD
Bumetanide—CA9—Cellular response to hypoxia—EP300—systemic lupus erythematosus	0.000184	0.00664	CbGpPWpGaD
Bumetanide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.00018	0.00165	CcSEcCtD
Bumetanide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.00018	0.00165	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000178	0.00164	CcSEcCtD
Bumetanide—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000178	0.00163	CcSEcCtD
Bumetanide—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000178	0.00163	CcSEcCtD
Bumetanide—Vertigo—Prednisone—systemic lupus erythematosus	0.000176	0.00162	CcSEcCtD
Bumetanide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000176	0.00162	CcSEcCtD
Bumetanide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000175	0.00161	CcSEcCtD
Bumetanide—CA9—Cellular response to hypoxia—VEGFA—systemic lupus erythematosus	0.000175	0.00629	CbGpPWpGaD
Bumetanide—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000175	0.0016	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUNB—systemic lupus erythematosus	0.000174	0.00628	CbGpPWpGaD
Bumetanide—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000174	0.0016	CcSEcCtD
Bumetanide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000174	0.0016	CcSEcCtD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000172	0.00619	CbGpPWpGaD
Bumetanide—Hypotension—Betamethasone—systemic lupus erythematosus	0.000172	0.00158	CcSEcCtD
Bumetanide—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000172	0.00158	CcSEcCtD
Bumetanide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000171	0.00157	CcSEcCtD
Bumetanide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000171	0.00157	CcSEcCtD
Bumetanide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00017	0.00156	CcSEcCtD
Bumetanide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000169	0.00156	CcSEcCtD
Bumetanide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.00153	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000167	0.00153	CcSEcCtD
Bumetanide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000166	0.00152	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000165	0.00152	CcSEcCtD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000163	0.00586	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000162	0.00582	CbGpPWpGaD
Bumetanide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00148	CcSEcCtD
Bumetanide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000161	0.00148	CcSEcCtD
Bumetanide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00016	0.00147	CcSEcCtD
Bumetanide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00016	0.00147	CcSEcCtD
Bumetanide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00016	0.00147	CcSEcCtD
Bumetanide—PTGS2—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000159	0.00571	CbGpPWpGaD
Bumetanide—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000158	0.00146	CcSEcCtD
Bumetanide—Fatigue—Betamethasone—systemic lupus erythematosus	0.000158	0.00146	CcSEcCtD
Bumetanide—PTGS2—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000156	0.00563	CbGpPWpGaD
Bumetanide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000156	0.00143	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000155	0.00142	CcSEcCtD
Bumetanide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000154	0.00142	CcSEcCtD
Bumetanide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000154	0.00141	CcSEcCtD
Bumetanide—Rash—Cyclosporine—systemic lupus erythematosus	0.000153	0.0014	CcSEcCtD
Bumetanide—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000152	0.0014	CcSEcCtD
Bumetanide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000152	0.0014	CcSEcCtD
Bumetanide—Headache—Cyclosporine—systemic lupus erythematosus	0.000152	0.00139	CcSEcCtD
Bumetanide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.00015	0.00138	CcSEcCtD
Bumetanide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.00015	0.00138	CcSEcCtD
Bumetanide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.00138	CcSEcCtD
Bumetanide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00137	CcSEcCtD
Bumetanide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00137	CcSEcCtD
Bumetanide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.00136	CcSEcCtD
Bumetanide—Vertigo—Methotrexate—systemic lupus erythematosus	0.000147	0.00135	CcSEcCtD
Bumetanide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00135	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000147	0.00135	CcSEcCtD
Bumetanide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000146	0.00134	CcSEcCtD
Bumetanide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000146	0.00134	CcSEcCtD
Bumetanide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000146	0.00134	CcSEcCtD
Bumetanide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000145	0.00133	CcSEcCtD
Bumetanide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000145	0.00133	CcSEcCtD
Bumetanide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000145	0.00133	CcSEcCtD
Bumetanide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000145	0.00133	CcSEcCtD
Bumetanide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000144	0.00132	CcSEcCtD
Bumetanide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000143	0.00132	CcSEcCtD
Bumetanide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000143	0.00131	CcSEcCtD
Bumetanide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000142	0.00131	CcSEcCtD
Bumetanide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.00129	CcSEcCtD
Bumetanide—Chest pain—Methotrexate—systemic lupus erythematosus	0.000139	0.00128	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000139	0.00128	CcSEcCtD
Bumetanide—Rash—Prednisolone—systemic lupus erythematosus	0.000139	0.00128	CcSEcCtD
Bumetanide—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000139	0.00127	CcSEcCtD
Bumetanide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00127	CcSEcCtD
Bumetanide—Fatigue—Prednisone—systemic lupus erythematosus	0.000138	0.00127	CcSEcCtD
Bumetanide—Headache—Prednisolone—systemic lupus erythematosus	0.000138	0.00127	CcSEcCtD
Bumetanide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00126	CcSEcCtD
Bumetanide—Rash—Hydrocortisone—systemic lupus erythematosus	0.000136	0.00125	CcSEcCtD
Bumetanide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000135	0.00124	CcSEcCtD
Bumetanide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000135	0.00124	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—systemic lupus erythematosus	0.000135	0.00485	CbGpPWpGaD
Bumetanide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000134	0.00123	CcSEcCtD
Bumetanide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000134	0.00123	CcSEcCtD
Bumetanide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000132	0.00121	CcSEcCtD
Bumetanide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000132	0.00121	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—systemic lupus erythematosus	0.000131	0.00471	CbGpPWpGaD
Bumetanide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000131	0.0012	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000131	0.0012	CcSEcCtD
Bumetanide—Nausea—Prednisolone—systemic lupus erythematosus	0.000131	0.0012	CcSEcCtD
Bumetanide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00013	0.00119	CcSEcCtD
Bumetanide—Pruritus—Betamethasone—systemic lupus erythematosus	0.00013	0.00119	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000129	0.00119	CcSEcCtD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000129	0.00464	CbGpPWpGaD
Bumetanide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000129	0.00118	CcSEcCtD
Bumetanide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000128	0.00118	CcSEcCtD
Bumetanide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000128	0.00117	CcSEcCtD
Bumetanide—Rash—Triamcinolone—systemic lupus erythematosus	0.000128	0.00117	CcSEcCtD
Bumetanide—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000128	0.00117	CcSEcCtD
Bumetanide—Rash—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00117	CcSEcCtD
Bumetanide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00117	CcSEcCtD
Bumetanide—Urticaria—Prednisone—systemic lupus erythematosus	0.000127	0.00117	CcSEcCtD
Bumetanide—Headache—Triamcinolone—systemic lupus erythematosus	0.000127	0.00117	CcSEcCtD
Bumetanide—Headache—Methylprednisolone—systemic lupus erythematosus	0.000127	0.00116	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000126	0.00116	CcSEcCtD
Bumetanide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000126	0.00116	CcSEcCtD
Bumetanide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000126	0.00116	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—systemic lupus erythematosus	0.000125	0.0045	CbGpPWpGaD
Bumetanide—Hypotension—Methotrexate—systemic lupus erythematosus	0.000125	0.00115	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000122	0.00438	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000122	0.00438	CbGpPWpGaD
Bumetanide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000121	0.00112	CcSEcCtD
Bumetanide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000121	0.00112	CcSEcCtD
Bumetanide—SLCO1A2—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000121	0.00435	CbGpPWpGaD
Bumetanide—Nausea—Triamcinolone—systemic lupus erythematosus	0.00012	0.00111	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—systemic lupus erythematosus	0.00012	0.00432	CbGpPWpGaD
Bumetanide—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00012	0.0011	CcSEcCtD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000117	0.00421	CbGpPWpGaD
Bumetanide—Vomiting—Betamethasone—systemic lupus erythematosus	0.000117	0.00107	CcSEcCtD
Bumetanide—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000117	0.00107	CcSEcCtD
Bumetanide—Rash—Betamethasone—systemic lupus erythematosus	0.000116	0.00106	CcSEcCtD
Bumetanide—Rash—Dexamethasone—systemic lupus erythematosus	0.000116	0.00106	CcSEcCtD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000116	0.00417	CbGpPWpGaD
Bumetanide—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000116	0.00106	CcSEcCtD
Bumetanide—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000116	0.00106	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—systemic lupus erythematosus	0.000115	0.00106	CcSEcCtD
Bumetanide—Headache—Betamethasone—systemic lupus erythematosus	0.000115	0.00106	CcSEcCtD
Bumetanide—Headache—Dexamethasone—systemic lupus erythematosus	0.000115	0.00106	CcSEcCtD
Bumetanide—Asthenia—Prednisone—systemic lupus erythematosus	0.000115	0.00105	CcSEcCtD
Bumetanide—Pruritus—Prednisone—systemic lupus erythematosus	0.000113	0.00104	CcSEcCtD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.000113	0.00406	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000112	0.00403	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—HIST2H2AC—systemic lupus erythematosus	0.000111	0.00398	CbGpPWpGaD
Bumetanide—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000109	0.00101	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000109	0.001	CcSEcCtD
Bumetanide—Nausea—Dexamethasone—systemic lupus erythematosus	0.000109	0.001	CcSEcCtD
Bumetanide—Nausea—Betamethasone—systemic lupus erythematosus	0.000109	0.001	CcSEcCtD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000109	0.00392	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000109	0.00392	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000109	0.00392	CbGpPWpGaD
Bumetanide—Urticaria—Methotrexate—systemic lupus erythematosus	0.000106	0.000976	CcSEcCtD
Bumetanide—Dizziness—Prednisone—systemic lupus erythematosus	0.000106	0.000972	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000106	0.000971	CcSEcCtD
Bumetanide—PTGS2—Spinal Cord Injury—TNFSF13—systemic lupus erythematosus	0.000104	0.00375	CbGpPWpGaD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000103	0.00372	CbGpPWpGaD
Bumetanide—Vomiting—Prednisone—systemic lupus erythematosus	0.000102	0.000935	CcSEcCtD
Bumetanide—Rash—Prednisone—systemic lupus erythematosus	0.000101	0.000927	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—systemic lupus erythematosus	0.000101	0.000926	CcSEcCtD
Bumetanide—Headache—Prednisone—systemic lupus erythematosus	0.0001	0.000921	CcSEcCtD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	9.84e-05	0.00354	CbGpPWpGaD
Bumetanide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—systemic lupus erythematosus	9.62e-05	0.00346	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—ETS1—systemic lupus erythematosus	9.6e-05	0.00345	CbGpPWpGaD
Bumetanide—Asthenia—Methotrexate—systemic lupus erythematosus	9.59e-05	0.000882	CcSEcCtD
Bumetanide—Nausea—Prednisone—systemic lupus erythematosus	9.5e-05	0.000873	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—systemic lupus erythematosus	9.46e-05	0.000869	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.26e-05	0.00333	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—ETS1—systemic lupus erythematosus	9.25e-05	0.00333	CbGpPWpGaD
Bumetanide—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.15e-05	0.000841	CcSEcCtD
Bumetanide—Dizziness—Methotrexate—systemic lupus erythematosus	8.84e-05	0.000813	CcSEcCtD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	8.74e-05	0.00315	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	8.71e-05	0.00313	CbGpPWpGaD
Bumetanide—Vomiting—Methotrexate—systemic lupus erythematosus	8.5e-05	0.000781	CcSEcCtD
Bumetanide—CA9—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	8.49e-05	0.00305	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	8.47e-05	0.00305	CbGpPWpGaD
Bumetanide—Rash—Methotrexate—systemic lupus erythematosus	8.43e-05	0.000775	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—systemic lupus erythematosus	8.42e-05	0.000774	CcSEcCtD
Bumetanide—PTGS2—S1P1 pathway—VEGFA—systemic lupus erythematosus	8.39e-05	0.00302	CbGpPWpGaD
Bumetanide—Headache—Methotrexate—systemic lupus erythematosus	8.38e-05	0.00077	CcSEcCtD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	8.22e-05	0.00296	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	8.1e-05	0.00291	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	8.04e-05	0.00289	CbGpPWpGaD
Bumetanide—Nausea—Methotrexate—systemic lupus erythematosus	7.94e-05	0.00073	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—systemic lupus erythematosus	7.92e-05	0.00285	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	7.76e-05	0.00279	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	7.19e-05	0.00259	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	7.09e-05	0.00255	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—systemic lupus erythematosus	7.04e-05	0.00253	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—systemic lupus erythematosus	6.24e-05	0.00225	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.18e-05	0.00222	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.18e-05	0.00222	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.18e-05	0.00222	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.15e-05	0.00221	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	6.02e-05	0.00217	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	5.8e-05	0.00209	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.51e-05	0.00198	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NAT2—systemic lupus erythematosus	5.36e-05	0.00193	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.26e-05	0.00189	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NAT2—systemic lupus erythematosus	5.23e-05	0.00188	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	5.12e-05	0.00184	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	4.97e-05	0.00179	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NAT2—systemic lupus erythematosus	4.88e-05	0.00176	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NAT2—systemic lupus erythematosus	4.88e-05	0.00176	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.76e-05	0.00171	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	4.66e-05	0.00168	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	4.59e-05	0.00165	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	4.55e-05	0.00164	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NAT2—systemic lupus erythematosus	4.52e-05	0.00163	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	4.37e-05	0.00157	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—F2—systemic lupus erythematosus	4.3e-05	0.00155	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL4—systemic lupus erythematosus	4.26e-05	0.00153	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	4.14e-05	0.00149	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.09e-05	0.00147	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.86e-05	0.00139	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	3.83e-05	0.00138	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NAT2—systemic lupus erythematosus	3.78e-05	0.00136	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.67e-05	0.00132	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NAT2—systemic lupus erythematosus	3.6e-05	0.0013	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	3.57e-05	0.00128	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	3.54e-05	0.00128	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—systemic lupus erythematosus	3.53e-05	0.00127	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.38e-05	0.00122	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.33e-05	0.0012	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	3.32e-05	0.00119	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.29e-05	0.00118	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CD4—systemic lupus erythematosus	3.27e-05	0.00118	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	3.26e-05	0.00117	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CDKN1B—systemic lupus erythematosus	3.19e-05	0.00115	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.13e-05	0.00112	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	3.07e-05	0.0011	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	3.03e-05	0.00109	CbGpPWpGaD
Bumetanide—CA14—Metabolism—RXRA—systemic lupus erythematosus	3.01e-05	0.00108	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3e-05	0.00108	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.98e-05	0.00107	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CDKN1A—systemic lupus erythematosus	2.94e-05	0.00106	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—RXRA—systemic lupus erythematosus	2.93e-05	0.00105	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NAT2—systemic lupus erythematosus	2.91e-05	0.00105	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	2.83e-05	0.00102	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.8e-05	0.00101	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—EP300—systemic lupus erythematosus	2.8e-05	0.00101	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.77e-05	0.000997	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—RXRA—systemic lupus erythematosus	2.73e-05	0.000984	CbGpPWpGaD
Bumetanide—CA7—Metabolism—RXRA—systemic lupus erythematosus	2.73e-05	0.000984	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.7e-05	0.000971	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	2.7e-05	0.00097	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.67e-05	0.000962	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—systemic lupus erythematosus	2.65e-05	0.000954	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	2.58e-05	0.000927	CbGpPWpGaD
Bumetanide—CA12—Metabolism—RXRA—systemic lupus erythematosus	2.53e-05	0.000912	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.51e-05	0.000901	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.49e-05	0.000894	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.36e-05	0.00085	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	2.34e-05	0.000842	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.34e-05	0.000842	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.34e-05	0.000841	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	2.29e-05	0.000824	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.22e-05	0.0008	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	2.17e-05	0.00078	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—RXRA—systemic lupus erythematosus	2.12e-05	0.000762	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	2.11e-05	0.000759	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.09e-05	0.000752	CbGpPWpGaD
Bumetanide—CA4—Metabolism—RXRA—systemic lupus erythematosus	2.02e-05	0.000727	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.96e-05	0.000707	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPARG—systemic lupus erythematosus	1.9e-05	0.000683	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.87e-05	0.000671	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NAT2—systemic lupus erythematosus	1.86e-05	0.000669	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPARG—systemic lupus erythematosus	1.85e-05	0.000665	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—systemic lupus erythematosus	1.83e-05	0.00066	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	1.79e-05	0.000643	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPARG—systemic lupus erythematosus	1.73e-05	0.000621	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPARG—systemic lupus erythematosus	1.73e-05	0.000621	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—systemic lupus erythematosus	1.71e-05	0.000614	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.7e-05	0.000612	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.69e-05	0.000609	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.67e-05	0.0006	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—systemic lupus erythematosus	1.66e-05	0.000598	CbGpPWpGaD
Bumetanide—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.66e-05	0.000598	CbGpPWpGaD
Bumetanide—CA9—Metabolism—RXRA—systemic lupus erythematosus	1.63e-05	0.000587	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NOS3—systemic lupus erythematosus	1.63e-05	0.000587	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPARG—systemic lupus erythematosus	1.6e-05	0.000576	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.59e-05	0.000573	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NOS3—systemic lupus erythematosus	1.59e-05	0.000572	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—systemic lupus erythematosus	1.55e-05	0.000559	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—systemic lupus erythematosus	1.55e-05	0.000559	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—systemic lupus erythematosus	1.49e-05	0.000537	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—systemic lupus erythematosus	1.49e-05	0.000534	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—systemic lupus erythematosus	1.49e-05	0.000534	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.48e-05	0.000532	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.47e-05	0.000529	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—systemic lupus erythematosus	1.45e-05	0.000523	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—systemic lupus erythematosus	1.44e-05	0.000517	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.42e-05	0.000512	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.41e-05	0.000508	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.4e-05	0.000503	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—systemic lupus erythematosus	1.38e-05	0.000495	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—systemic lupus erythematosus	1.36e-05	0.000489	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—systemic lupus erythematosus	1.36e-05	0.000489	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.35e-05	0.000484	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—systemic lupus erythematosus	1.34e-05	0.000481	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.33e-05	0.000478	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.32e-05	0.000476	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—systemic lupus erythematosus	1.28e-05	0.000459	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.26e-05	0.000454	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—systemic lupus erythematosus	1.26e-05	0.000453	CbGpPWpGaD
Bumetanide—CA14—Metabolism—EP300—systemic lupus erythematosus	1.24e-05	0.000447	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.23e-05	0.000441	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.22e-05	0.000437	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—EP300—systemic lupus erythematosus	1.21e-05	0.000435	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—systemic lupus erythematosus	1.2e-05	0.000433	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CSK—systemic lupus erythematosus	1.19e-05	0.00043	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.19e-05	0.000427	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.16e-05	0.000418	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—systemic lupus erythematosus	1.15e-05	0.000414	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—systemic lupus erythematosus	1.15e-05	0.000413	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.13e-05	0.000408	CbGpPWpGaD
Bumetanide—CA7—Metabolism—EP300—systemic lupus erythematosus	1.13e-05	0.000406	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—EP300—systemic lupus erythematosus	1.13e-05	0.000406	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD247—systemic lupus erythematosus	1.12e-05	0.000404	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.12e-05	0.000404	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—systemic lupus erythematosus	1.1e-05	0.000395	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.09e-05	0.000393	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—systemic lupus erythematosus	1.05e-05	0.000378	CbGpPWpGaD
Bumetanide—CA12—Metabolism—EP300—systemic lupus erythematosus	1.05e-05	0.000377	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RXRA—systemic lupus erythematosus	1.04e-05	0.000375	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—systemic lupus erythematosus	1.03e-05	0.000371	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—systemic lupus erythematosus	1e-05	0.000361	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.67e-06	0.000348	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—systemic lupus erythematosus	9.27e-06	0.000333	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.92e-06	0.000321	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—systemic lupus erythematosus	8.87e-06	0.000319	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—EP300—systemic lupus erythematosus	8.75e-06	0.000315	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JUNB—systemic lupus erythematosus	8.57e-06	0.000308	CbGpPWpGaD
Bumetanide—CA4—Metabolism—EP300—systemic lupus erythematosus	8.35e-06	0.0003	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—systemic lupus erythematosus	8.11e-06	0.000292	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.02e-06	0.000289	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRL—systemic lupus erythematosus	7.9e-06	0.000284	CbGpPWpGaD
Bumetanide—CA9—Metabolism—EP300—systemic lupus erythematosus	6.74e-06	0.000243	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—systemic lupus erythematosus	6.58e-06	0.000237	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAK1—systemic lupus erythematosus	6.32e-06	0.000227	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	6.29e-06	0.000226	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CCR5—systemic lupus erythematosus	5.99e-06	0.000215	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—systemic lupus erythematosus	5.92e-06	0.000213	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.84e-06	0.00021	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—systemic lupus erythematosus	5.66e-06	0.000204	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—systemic lupus erythematosus	5.18e-06	0.000186	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD80—systemic lupus erythematosus	4.92e-06	0.000177	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—EP300—systemic lupus erythematosus	4.3e-06	0.000155	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TYK2—systemic lupus erythematosus	4.16e-06	0.00015	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—systemic lupus erythematosus	4.08e-06	0.000147	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	3.97e-06	0.000143	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—systemic lupus erythematosus	3.76e-06	0.000135	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—systemic lupus erythematosus	3.57e-06	0.000129	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	3.53e-06	0.000127	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	3.42e-06	0.000123	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	3.26e-06	0.000117	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EP300—systemic lupus erythematosus	3.1e-06	0.000112	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—systemic lupus erythematosus	2.7e-06	9.71e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—EP300—systemic lupus erythematosus	2.6e-06	9.35e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—systemic lupus erythematosus	2.03e-06	7.32e-05	CbGpPWpGaD
